U.S., Aug. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07790198) titled 'Tezepelumab CRSwNP Real World Study (CREW Study)' on Aug. 18.
Brief Summary: The CREW Study is a non-interventional prospective, observational study in patients with CRSwNP that will evaluate patient-reported outcomes and describe the proportion of participants achieving treatment goals.)
Study Start Date: Oct. 01
Study Type: OBSERVATIONAL
Condition:
Chronic Rhinosinusitis With Nasal Polyps
Intervention:
DRUG: Tezepelumab
Subcutaneous (SC) tezepelumab indicated as add-on therapy for the treatment of participants with severe CRSwNP as part of routine clinical care.
Recruitment Status: NOT_YET_RECRUITING
Sponsor: AstraZeneca...